breast cancer prevention
Oncology · 2016–2016
1decision
1medicine
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| tamoxifen Primary prevention of breast cancer in women at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk… | Mar 2016 | Recommended with restriction | input received Breast Cancer Network Australia |
Who spoke
Breast Cancer Network Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.